Search results
Results From The WOW.Com Content Network
The diffuse leprosy of Lucio and Latapí, also known as diffuse lepromatous leprosy or "pretty leprosy", is a clinical variety of lepromatous leprosy. It was first described by Lucio and Alvarado in 1852 and re-identified by Latapí in 1936. It is common in Mexico (23% of leprosy cases) and in Costa Rica and very rare in other countries.
Lucio's phenomenon is an unusual reaction seen almost exclusively in patients from the Caribbean and Mexico with diffuse lepromatous leprosy, especially in untreated cases. It is characterised by recurrent crops of large, sharply demarcated, ulcerative lesions, affecting mainly the lower extremities, but may generalise and become fatal as a ...
Leprosy has historically been associated with social stigma, which continues to be a barrier to self-reporting and early treatment. [4] Leprosy is classified as a neglected tropical disease. [21] World Leprosy Day was started in 1954 to draw awareness to those affected by leprosy. [22] [4] The study of leprosy and its treatment is known as ...
Rafael Lucio Nájera (September 2, 1819 – May 30, 1886) was a Mexican physician, academic and scientist born in Xalapa-Enríquez, Veracruz, who devoted many years of his life to research leprosy. Biography
Leprosy, sometimes known as Hansen's disease, is an infectious disease caused by Mycobacterium leprae, an aerobic, acid-fast, rod-shaped mycobacterium. The modern term for the disease is named after the discoverer of the bacterium, Gerhard Armauer Hansen .
These three anti-leprosy drugs are still used in the standard MDT regimens. None of them is used alone because of the risk of developing resistance. As this treatment was quite expensive, it was not quickly adopted in most countries where the disease is endemic. In 1985, leprosy was still considered a public health problem in 122 countries.
Mycobacterium leprae (also known as the leprosy bacillus or Hansen's bacillus) is one [a] of the two species of bacteria that cause Hansen's disease (leprosy), [1] a chronic but curable infectious disease that damages the peripheral nerves and targets the skin, eyes, nose, and muscles.
Spinalonga on Crete, Greece, one of the last leprosy colonies in Europe, closed in 1957. A leper colony, also known by many other names, is an isolated community for the quarantining and treatment of lepers, people suffering from leprosy.